Piramal Pharma Share Price Target 2025, 2026, 2027 to 2030

Do you want to know the Piramal Pharma share price target for the year 2025? Here, you will get a detailed analysis of the company’s financial performance, historical data, and price target for the year 2025, 2026, 2027, 2028, 2029, and 2030 provided by the market experts and analysts.

About Piramal Pharma Limited

Piramal Pharma is an Indian company that makes medicines to help people feel better. It started working as a separate company in 2020 and is based in Mumbai. The company makes different kinds of medicine, like those used in hospitals and some you can buy at a shop without a doctor’s note. Piramal also helps other companies by making and testing their medicines. It sells its products in many countries. The goal of Piramal Pharma is to make good-quality medicine that helps people stay healthy.

Piramal Pharma Fundamentals

• Market Cap: ₹27,628.42 Cr.
• P/E Ratio: 39.96
• Book Value: ₹55.62
• Dividend Yield: 0.07 %
• ROE: 9.83 %
• ROCE: 12.40%
• 52-Week High: ₹307.85
• 52-Week Low: ₹145.55

Ola Electric Shareholding Pattern

• Promoter: 34.95%
• FII: 31.49%
• DII: 2.05%
• Public: 12.73%
• Others: 18.78%

Piramal Pharma Share Price Historical Data

Piramal Pharma Share Price Target 2025

In 2025, the minimum price of Piramal Pharma shares will be ₹230. Over the year, it is expected to go up little by little and its maximum price could reach about ₹245. So, the stock may trade between ₹230 and ₹245 during the year.

Ola Electric Share Price Target 2026

In 2026, the minimum price of Piramal Pharma shares will be ₹375. Over the year, it is expected to go up little by little and its maximum price could reach about ₹390. So, the stock may trade between ₹375 and ₹390 during the year.

Ola Electric Share Price Target 2027

In 2027, the minimum price of Piramal Pharma shares will be ₹510. Over the year, it is expected to go up little by little and its maximum price could reach about ₹530. So, the stock may trade between ₹510 and ₹530 during the year.

Ola Electric Share Price Target 2028

In 2028, the minimum price of Piramal Pharma shares will be ₹690. Over the year, it is expected to go up little by little and its maximum price could reach about ₹720. So, the stock may trade between ₹690 and ₹720 during the year.

Ola Electric Share Price Target 2029

In 2029, the minimum price of Piramal Pharma shares will be ₹850. Over the year, it is expected to go up little by little and its maximum price could reach about ₹890. So, the stock may trade between ₹850 and ₹890 during the year.

Ola Electric Share Price Target 2030

In 2030, the minimum price of Piramal Pharma shares will be ₹1050. Over the year, it is expected to go up little by little and its maximum price could reach about ₹1180. So, the stock may trade between ₹1050 and ₹1180 during the year.

Also Read: TCS Share Price Target 2025, 2026, 2027 to 2030

Piramal Pharma Financials

In the financials section of Piramal Pharma Ltd, we will discuss its income statement and balance sheet, so you can decide whether this stock is good for you or not for trade.

Piramal Pharma Income Statement

This company earned ₹2,754 crore, which is a little more than last year. It spent ₹1,481 crore to run the business — and that cost was much higher than before. Still, it made a profit of ₹154 crore, which is a good improvement. Each share gave ₹1.16 to its owner. The company is earning more and saving more, though its costs are growing fast too. It should keep an eye on spending.

Piramal Pharma Balance Sheet

The company owns things worth ₹15,678 crore in total. Out of that, ₹521 crore is in cash and short-term savings — a small increase. It has to pay ₹7,552 crore to others. After paying that, ₹8,125 crore is left, which belongs to the owners. The company has around 132 crore shares. It’s in a good financial position and is growing steadily.

Piramal Pharma Peer Companies

The peer companies of Piramal Pharma Limited which are in tough competition are Sun Pharmaceutical Industries, Cipla, Dr. Reddy’s Laboratories, Lupin, Aurobindo Pharma, Zydus Lifesciences, Glenmark Pharmaceuticals, Torrent Pharmaceuticals, Biocon, Jubilant Pharmova, Laurus Labs, Divi’s Laboratories.

F&Q